BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/11/2014 2:06:00 PM | Browse: 1153 | Download: 1647
 |
Received |
|
2014-05-03 19:03 |
|
Peer-Review Started |
|
2014-05-04 10:51 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-05-16 16:44 |
|
Revised |
|
2014-07-19 01:14 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-10-10 18:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-10-10 18:12 |
|
Articles in Press |
|
2014-10-10 18:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2014-11-18 09:06 |
|
Publish the Manuscript Online |
|
2014-12-11 14:23 |
| Category |
Oncology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Navneet Singh, Aditya Jindal and Digambar Behera |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Navneet Singh, MD, DM, FACP, FCCP, FICS, Assistant Professor, Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. singh.navneet@pgimer.edu.in |
| Key Words |
Gefitinib; Erlotinib; Non-small cell lung cancer; Epidermal growth factor receptor; Tyrosine kinase inhibitor |
| Core Tip |
This manuscript is focused on the controversial yet interesting topic of whether erlotinib provides clinical benefit amongst patients who have experienced disease progression after prior therapy with gefitinib-both drugs being tyrosine kinase inhibitors of the epidermal growth factor receptor. We have reviewed available literature on this topic, carried out a pooled analysis on available data and hope readers find it useful in clearing the confusion related to this topic. |
| Publish Date |
2014-12-11 14:23 |
| Citation |
Singh N, Jindal A, Behera D. Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature. World J Clin Oncol 2014; 5(5): 858-864 |
| URL |
http://www.wjgnet.com/2218-4333/full/v5/i5/858.htm |
| DOI |
http://dx.doi.org/10.5306/wjco.v5.i5.858 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
